RIGEL PHARMACEUTICALS INC - 8-K Filing
On May 14, 2026, Rigel Pharmaceuticals stockholders approved amendments to the company's 2018 Equity Incentive Plan (adding 500,000 shares) and its 2000 Employee Stock Purchase Plan (adding 360,000 shares). The Annual Meeting also resulted in the election of directors Alison Hannah, Walter Moos, and Raul Rodriguez. Additionally, stockholders approved executive compensation on an advisory basis and ratified Ernst & Young as the independent auditor. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 5.07 Submission of Matters to a Vote of Security Holders)
Tickers: $RIGL